An interdisciplinary European group of clinical experts in the field of movement disorders
and experienced Botulinum toxin users has updated the consensus for the use of Botulinum …

Objective: To perform an evidence-based review of the safety and efficacy of botulinum
neurotoxin (BoNT) in the treatment of adult and childhood spasticity. Methods: A literature …

Gross Motor Function Measure (GMFM-66 & GMFM-88) users manual : Research Bank Skip
to content Australian Catholic University Home About People Research areas Latest …

Treatment of Cerebral Palsy and Motor Delay is a highly practical, easy-to-read resource for
all paediatric practitioners and students working with the developmental abilities and …

Objetivo: a revisão da paralisia cerebral tem como objetivo oferecer ao pediatra
informações atualizadas sobre o diagnóstico e tratamento. Fontes dos dados: foram …

Objective: To evaluate published evidence of efficacy and safety of pharmacologic
treatments for childhood spasticity due to cerebral palsy. Methods: A multidisciplinary panel …

Botulinum toxin A (BoNT-A) is considered a safe and effective therapy for children with
cerebral palsy (CP), especially in the hands of experienced injectors and for the majority of …

Botulinum neurotoxin type‐A (BoNT‐A) has been used in association with other
interventions in the management of spasticity in children with cerebral palsy (CP) for almost …

OBJECTIVE: Task-specific body-weight-supported treadmill therapy improves walking
performance in children with central gait impairment. The aim of the study was to investigate …

Object Large-scale natural history studies of gross motor development have shown that
children with spastic cerebral palsy (CP) plateau during childhood and actually decline …